The global sheath catheter market is a steady, mid‑size interventional devices space that underpins vascular access for cardiology, urology, and peripheral procedures. It is being shaped by the shift toward minimally invasive care, an ageing patient base, and incremental but meaningful product innovation in materials and coatings.

The market was valued at around USD 1.9 billion in 2024 and is projected to reach roughly USD 3.5 billion by 2035, growing at a CAGR of about 5.9%. Growth is supported by rising cardiovascular disease burden, more catheter‑based interventions, and continuous improvements in catheter design that aim to reduce trauma, kinking, and infection risk.

Vascular intervention is the largest application segment, reflecting the central role of sheath catheters in angiography, electrophysiology, and structural heart procedures. Urological and cardiology applications also contribute meaningfully, with steady demand from both diagnostic and therapeutic workflows. By type, the market spans sheath introducers, diagnostic sheath catheters, and therapeutic sheath catheters, each serving distinct procedural needs from initial access to device delivery.

Material choice is a key differentiator. Polyurethane offers strength and kink resistance, silicone provides excellent biocompatibility and low friction, and PVC remains a cost‑effective option for many routine applications. Manufacturers are increasingly focusing on hydrophilic coatings, antimicrobial surfaces, and radiopaque markers to improve ease of insertion, safety, and imaging visibility.

Hospitals remain the dominant end‑user, given the volume of inpatient and complex interventional procedures, while ambulatory surgical centers and specialized clinics are gaining share as more procedures migrate to outpatient settings. Regionally, North America leads due to advanced infrastructure and high procedural volumes, while Asia‑Pacific is expected to grow faster as healthcare spending and interventional capacity expand.

Competitive dynamics revolve around reliability, procedural performance, and distribution reach. Leading players include Boston Scientific, Medtronic, Abbott, Terumo, Teleflex, Cook Medical, B. Braun, and others, with recent activity focused on next‑generation vascular access sheaths, hydrophilic coatings, and strategic partnerships to broaden portfolios.

Read more: Global Sheath Catheter Market Research Report

People Also Ask

Q1. What are sheath catheters used for in interventional procedures?
Sheath catheters are primarily used to create a stable, controlled entry point into blood vessels or other body lumens, allowing clinicians to introduce guidewires, balloons, stents, ablation catheters, and other interventional devices with minimal trauma. They are widely used in vascular interventions, cardiology procedures such as angiography and electrophysiology studies, urological procedures, and peripheral vascular work.

Q2. Which materials are most commonly used in sheath catheters?
The most common materials are polyurethane, silicone, and polyvinyl chloride (PVC). Polyurethane is valued for its strength and kink resistance, silicone for its biocompatibility and low friction, and PVC for its cost‑effectiveness and versatility. Manufacturers are also adding hydrophilic coatings, antimicrobial surfaces, and radiopaque markers to enhance safety and ease of use.

Tags: sheath catheter market, vascular access, interventional cardiology, urology devices, minimally invasive procedures, medical devices